Department of Otolaryngology-Head & Neck Surgery, Stanford University School of Medicine, Stanford, California, USA.
Stanford University School of Medicine, Stanford, California, USA.
Otolaryngol Head Neck Surg. 2024 Jan;170(1):13-19. doi: 10.1002/ohn.503. Epub 2023 Aug 18.
To determine whether nonopioid analgesic regimens, taken after discharge for thyroid and parathyroid surgery have noninferior pain outcomes in comparison to opioid analgesic regimens. Secondarily, we sought to determine if nonopioid analgesic regimens decrease the number of opioid medications taken after thyroid and parathyroid surgery, and to assess adverse events associated with opioid versus nonopioid regimens.
PubMed, Embase, Cochrane.
A comprehensive search of the literature was performed according to the PRISMA guidelines, and identified 1299 nonduplicate articles for initial review of which 2 randomized controlled trials (RCTs) were identified as meeting all eligibility criteria. Meta-analysis was not conducted due to heterogeneity in the data and statistical analyses.
Both RCTs included in this systematic review found no significant differences in postoperative pain scores between individuals discharged with a nonopioid only analgesic regimen compared to analgesic regimen that included oral opioid medications. One study reported significantly increased number of postoperative calls related specifically to pain in the nonopioid arm compared to the opioid arm (15.6% vs. 3.2%, P = .045).
This systematic review of RCTs revealed a limited number of studies examining nonopioid versus opioid postoperative pain medications among adults who undergo thyroid and parathyroid surgery. Among the 2 RCTs on this topic, there is a shared finding that nonopioid analgesic regimens are noninferior to opioid analgesic regimens in managing postoperative pain after thyroid and parathyroid surgery, supporting the use of nonopioid pain regimens given the risk of opioid dependence associated with prescription opioid medications.
确定甲状腺和甲状旁腺手术后出院时使用非阿片类镇痛药方案与阿片类镇痛药方案相比,是否具有非劣效性的疼痛结局。其次,我们试图确定非阿片类镇痛药方案是否会减少甲状腺和甲状旁腺手术后使用的阿片类药物数量,并评估阿片类药物与非阿片类药物方案相关的不良事件。
PubMed、Embase、Cochrane。
根据 PRISMA 指南进行了全面的文献检索,共检索到 1299 篇非重复文章进行初步审查,其中有 2 项随机对照试验(RCT)被确定为符合所有入选标准。由于数据和统计分析存在异质性,未进行荟萃分析。
这项系统评价纳入的两项 RCT 均未发现出院时使用非阿片类单一镇痛方案与包括口服阿片类药物的镇痛方案相比,术后疼痛评分有显著差异。一项研究报告称,非阿片类药物组与阿片类药物组相比,与疼痛相关的术后电话咨询次数明显增加(15.6%比 3.2%,P=0.045)。
这项对 RCT 的系统评价显示,研究成人甲状腺和甲状旁腺手术后非阿片类与阿片类术后疼痛药物的研究数量有限。在这两个关于该主题的 RCT 中,有一个共同的发现,即非阿片类镇痛方案在管理甲状腺和甲状旁腺手术后的术后疼痛方面不劣于阿片类镇痛方案,鉴于与处方阿片类药物相关的阿片类药物依赖风险,支持使用非阿片类疼痛方案。